Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TPE/3164 stock hub

TPE/3164 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

TPE/3164is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
1.5B
Taiwan Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
TPE/3164
In the news

Latest news · TPE/3164

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12P50 15.5P75 22.5
Trailing P/E33.4
P25 14.4P50 18P75 31.9
ROE2.5
P25 -16.2P50 0.3P75 9.8
ROIC2.6
P25 -11.7P50 -0.2P75 8.8
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All TPE/3164 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
235
Groups with data
11
Currency
TWD
Showing 235 of 235 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

16
MetricValue
Country
Taiwan
Country code
TW
Enterprise value
TWD 1.3B
Exchange
Taiwan Stock Exchange
Financial currency
TWD
First seen
2026-05-10
Industry
Biotechnology
Isin
TW0003164000
Last refreshed
2026-05-10
Market cap
TWD 1.5B
Price
TWD 17.4
Price currency
TWD
Sector
Healthcare
Sic
2834
Symbol
tpe/3164
Website
https://www.genmont.com.tw

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

13
MetricValue
Earnings Yield
3%
EV Earnings
29.89x
EV/EBIT
32.84x
EV/EBITDA
12.61x
EV/FCF
24.81x
EV/Sales
3.43x
FCF yield
3.61%
P/B ratio
1.06x
P/E ratio
33.41x
P/S ratio
3.83x
PE Ratio10 Y
37.62x
PE Ratio3 Y
47.34x
PE Ratio5 Y
39.65x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

25
MetricValue
EBIT Margin
10.45%
EBITDA Margin
26.5%
FCF margin
13.84%
Gross margin
60.69%
Gross Profit
TWD 237.3M
Gross Profit Growth
7.09%
Gross Profit Growth Q
-22.96%
Gross Profit Growth3 Y
-1.48%
Gross Profit Growth5 Y
0.18%
Net Income
TWD 44.9M
Net Income Growth
15.22%
Net Income Growth Q
-74.8%
Net Income Growth Years
0%
Net Income Growth3 Y
2.31%
Net Income Growth5 Y
-11.48%
Pretax Margin
12.42%
Profit Margin
11.48%
Profitable Years
9
ROA
1.48
Roa5y
2.18
ROCE
2.74
ROE
2.5
Roe5y
3.7
ROIC
2.58
Roic5y
3.89

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

27
MetricValue
Cagr10y
0.94%
Cagr15y
-7.83%
Cagr1y
-9.77%
Cagr20y
0.63%
Cagr3y
-7.81%
Cagr5y
-2.35%
Div CAGR10
-6.09%
Div CAGR3
4.55%
Div CAGR5
2.71%
EPS Growth
15.7
EPS Growth Q
-74.62
EPS Growth Years
0
EPS Growth3 Y
2.38
EPS Growth5 Y
-11.14
FCF Growth
-44.35%
FCF Growth Q
-51.39%
FCF Growth3 Y
-0.62%
OCF Growth
-47.73%
OCF Growth Q
-50.89%
OCF Growth10 Y
13.58%
OCF Growth3 Y
-19.65%
OCF Growth5 Y
-10.35%
Revenue Growth
6.12x
Revenue Growth Q
-10.34x
Revenue Growth Years
2x
Revenue Growth3 Y
3.05x
Revenue Growth5 Y
2.33x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

23
MetricValue
Asset Turnover
TWD 0.23
Assets
TWD 1.7B
Cash
TWD 387.4M
Current Assets
TWD 578.8M
Current Liabilities
TWD 209M
Debt
TWD 112.8M
Debt EBITDA
TWD 1.06
Debt Equity
TWD 0.08
Debt FCF
TWD 2.09
Equity
TWD 1.4B
Interest Coverage
10.85
Liabilities
TWD 297M
Long Term Assets
TWD 1.1B
Long Term Liabilities
TWD 88M
Net Cash
TWD 274.6M
Net Cash By Market Cap
TWD 18.35
Net Cash Growth
0.26%
Net Debt EBITDA
TWD -2.65
Net Debt Equity
TWD -0.2
Net Debt FCF
TWD -5.08
Tangible Book Value
TWD 1.3B
Tangible Book Value Per Share
TWD 14.93
WACC
4.72

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
2.77
Inventory Turnover
2.15
Net Working Capital
TWD 14.9M
Quick ratio
2.08
Working Capital
TWD 369.8M
Working Capital Turnover
TWD 1.09

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
0.84%
Dividend Growth
0%
Dividend Growth Years
1%
Dividend per share
TWD 0.8
Dividend Years
8
Dividend Yield
4.6%
Ex Div Date
2026-04-08
Last Dividend
TWD 0.8
Payout Frequency
Annual
Payout Ratio
154.18%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
9.79%
1Y total return
-9.77%
200-day SMA
18.81
3Y total return
-21.66%
50-day SMA
18.01
50-day SMA vs 200-day SMA
50under200
5Y total return
-11.2%
All Time High
114
All Time High Change
-84.74%
All Time High Date
2011-01-18
All Time Low
10
All Time Low Change
74%
All Time Low Date
2008-12-29
ATR
0.28
Beta
0.12
Beta1y
-0.04
Beta2y
0.27
Ch YTD
-5.18
High
17.75
High52
22.4
High52 Date
2025-07-17
High52ch
-22.32%
Low
17.4
Low52
17.2
Low52 Date
2026-03-09
Low52ch
1.16%
Ma50ch
-3.36%
Price vs 200-day SMA
-7.5%
RSI
34.28
RSI Monthly
28.17
RSI Weekly
33.38
Sharpe ratio
-0.68x
Sortino ratio
-0.55
Total Return
5.43%
Tr YTD
-0.92
Tr15y
-70.56%
Tr1m
-2.77%
Tr1w
-1.69%
Tr3m
1.29%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

5
MetricValue
Operating Income
TWD 40.9M
Operating Income Growth
103
Operating Income Growth3 Y
-0.19
Operating Income Growth5 Y
-14.73
Operating margin
10.45

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
55,917,746%
Net Borrowing
-1,104,000
Shares Insiders
21.77%
Shares Institutions
0.12%
Shares Out
86,010,400
Shares Qo Q
-0.63%
Shares Yo Y
-0.84%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

64
MetricValue
Adjusted FCF
TWD 54.1M
Average Volume
50,624.9x
Bv Per Share
14.95
CAPEX
TWD -3.5M
Ch10y
-18.12
Ch15y
-79.81
Ch1m
-6.95
Ch1w
-1.69
Ch1y
-13.65
Ch20y
-28.65
Ch3m
-3.06
Ch3y
-31.09
Ch5y
-27.5
Ch6m
-5.95
Change
-0.57%
Change From Open
-1.97
Close
17.5
Days Gap
1.43
Depreciation Amortization
62,730,000
Dollar Volume
946,681.8
Earnings Date
2026-05-15
EBIT
TWD 40.9M
EBITDA
TWD 103.6M
EPS
TWD 0.52
F Score
7
FCF
TWD 54.1M
FCF EV Yield
4.03x
FCF Per Share
TWD 0.63
Financing CF
-80,647,000
Fiscal Year End
December
Founded
2,000
Graham Number
13.23666
Graham Upside
-23.93
Income Tax
TWD 13M
Investing CF
37,877,000
Is Primary Listing
1
Last Earnings Date
2025-11-11
Last Report Date
2026-03-31
Last Split Date
2010-06-15
Last Split Type
Forward
Lynch Fair Value
TWD 2.6
Lynch Upside
-85.03
Ma150
18.34
Ma150ch
-5.12%
Ma20
17.81
Ma20ch
-2.32%
Net CF
15,989,000
Next Earnings Date
2026-05-15
Open
17.75
P FCF Ratio
27.67
P OCF Ratio
25.99
Payment Date
2026-05-08
Position In Range
0
Ppne
989,478,000
Price Date
2026-05-08
Price EBITDA
TWD 14.45
Ptbv Ratio
1.17
Relative Volume
1.08x
Revenue
390,947,000x
Tax By Revenue
3.32x
Tax Rate
26.71%
Tr20y
13.37%
Tr6m
-1.72%
Volume
54,407
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

TPE/3164 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+4.6%
$0.80 annual per share
Payout ratio
+154.2%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+2.7%
1 consecutive years of growth
Total shareholder yield
+5.4%
Next ex-dividend date: 2026-04-08
Performance

TPE/3164 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-9.8%
S&P 500 1Y: n/a
3Y total return
-21.7%
S&P 500 3Y: n/a
5Y total return
-11.2%
S&P 500 5Y: n/a
10Y total return
+9.8%
S&P 500 10Y: n/a
Ownership

Who owns TPE/3164?

Insider, institutional, and short-interest positioning.

Institutional ownership
+0.1%
Share of float held by funds and institutions
Insider ownership
+21.8%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-0.8%
Negative means the company is buying back shares.
Technical

TPE/3164 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
34.3
Neutral momentum band
Price vs 200-day MA
-7.5%
50/200-day relationship not available
Beta (5Y)
0.12
Less volatile than the market
Sharpe ratio
-0.68
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About TPE/3164

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpe/3164 stock rating?

tpe/3164 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpe/3164 analysis?

The full report lives at /stocks/tpe/3164/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpe/3164?

The latest report frames tpe/3164 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpe/3164 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.